Contact Us

Bi-Specific MAbs Market's 28% Growth Rate Is Mainly Due To Increasing Prevalence Of Cancer And Other Chronic Diseases

On August 04, 2021, EIN released an article on the bi-specific MAbs market, sourced from TBRC's Global Bi-Specific MAbs Market report. Global Bi-Specific MAbs Market by The Business Research Company is segmented as Catumaxomab (Removab), Blinatumomab, Duligotumab